pharmacovigilance of antimalaria drug treatment in enugu state, nigeria: community and health...
TRANSCRIPT
![Page 1: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/1.jpg)
Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community
and Health Workers’ Perceptions and Suggestions for Reporting Adverse Drug Events
Third International Conference for Improving Use of Medicines
Antalya, Turkey. November 14-18, 2011
Ajuba, Miriam Obinwanne Uzochukwu, Benjamin Chudi
Onwujekwe, Obinna Emmanuel15th November, 2011
![Page 2: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/2.jpg)
INTRODUCTION/BACKGROUND• Pharmacovigilance of antimalarial drugs is
important to both the individual and the community and it refers to detecting, assessing, understanding, and preventing the adverse reactions of antimalarial drugs.
• Malaria is endemic in Nigeria. • National Health Bill says, it is the duty of the
Federal Ministry of Health to issue guidelines and ensure the continuous monitoring, analysis and good use of drugs and poisons including medicines and medical devices.
![Page 3: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/3.jpg)
OBJECTIVES/STUDY QUESTIONS
• To determine the communities’ level of awareness of adverse drug reactions in malaria treatment and the reporting systems available, their attitudes, and their problems in reporting adverse events
• To provide suggestions towards alleviating these problems
![Page 4: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/4.jpg)
METHODS
• Study Area: Enugu State Nigeria made up of • Study design: Community based study that employed
the cross-sectional descriptive approach and the multistage sampling technique was used. The sampling frame was Enugu South LGA selected by simple random selection.
• Study population: 422 mothers and 60 health workers in Enugu South local government area of Enugu State, Nigeria
• Outcome measure(s): Community and health workers’ perceptions of pharmacovigilance for antimalarial treatment in Enugu and suggestions for reporting adverse drug events.
![Page 5: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/5.jpg)
RESULTS
![Page 6: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/6.jpg)
Figure 1: Community awareness of ADR following injection of antimalaria
![Page 7: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/7.jpg)
Table 2: Socio-demographic characteristics of health worker
![Page 8: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/8.jpg)
Figure 2: Action taken by respondents for ADR
![Page 9: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/9.jpg)
Figure 3: Problems that affect reporting ADR
![Page 10: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/10.jpg)
Figure 4: Suggestions to solving the problems
![Page 11: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/11.jpg)
IMPLICATIONS/CONCLUSIONS
• Most people do not report adverse reaction due to ignorance.
• To increase the reporting of ADRs.• Need to bridge the gap between reporting
ADRs and its awareness.
![Page 12: Pharmacovigilance of Antimalaria Drug Treatment in Enugu State, Nigeria: Community and Health Workers’ Perceptions and Suggestions for Reporting Adverse](https://reader038.vdocuments.us/reader038/viewer/2022100509/56649e6a5503460f94b67a6a/html5/thumbnails/12.jpg)
RECOMMENDATIONS
• Involvement of the media in creating awareness on pharmacovigilance.
• Training workshops for health workers and the general public.
• Regulation and monitoring of health facilities by the pharmacovigilance centres.
• Routine sampling of drugs on sale for quality.